Riluzole as a Dual-Targeted Radiosensitizer for Osteosarcoma: Targeting Tumor Cells and Angiogenic Vasculature to Enhance Single High Dose Radiotherapy Efficacy
Pooja Prakash Rao, Charis Herbert, Syeda Maryam Azeem, Elena Gary, Gloria Ho, Raisa Munira, Hadi Askarifirouzja, Adriana Haimovitz‐Friedman, Shahana S. Mahajan
This paper demonstrates that Riluzole enhances osteosarcoma radiosensitivity to single high dose radiotherapy by targeting both tumor cells and angiogenic vasculature.
International Journal of Radiation Oncology*Biology*Physics · Sep 1, 2025Peer-reviewedCancer Biology